Geron Announces Conference Call to Discuss Third Quarter 2017 Financial Results

MENLO PARK, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) will announce its financial results for the third quarter ended September 30, 2017, on Wednesday, November 1, 2017, after the market close. Geron’s management will also host a conference call for analysts and investors on Wednesday, November 1, 2017, at 4:30 p.m. Eastern Time to discuss the company’s third quarter results and recent events.

Participants can access the conference call live via telephone by dialing 877-303-9139 (U.S.); 760-536-5195 (international). The conference ID is 1056465. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at https://edge.media-server.com/m6/p/25tyxgih or at www.geron.com on the Investors pages, under Events. The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through December 1, 2017.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.Investor and Media Relations650-473-7765[email protected][email protected]

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Hyperscalers need $300 billion in annual AI revenue to break even: Goldman
• Sysco closes C$1.5 billion senior notes offering for Jetro acquisition